Zimmer Biomet Holdings, Inc.
ZBH
$100.91
$1.431.44%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.80% | 9.30% | 10.90% | 9.71% | 6.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.80% | 9.30% | 10.90% | 9.71% | 6.97% |
| Cost of Revenue | 7.31% | 2.62% | 38.30% | 3.84% | 6.97% |
| Gross Profit | 3.80% | 12.01% | 0.02% | 12.17% | 6.96% |
| SG&A Expenses | 9.30% | 11.80% | 19.27% | 14.78% | 10.09% |
| Depreciation & Amortization | 1.74% | 7.35% | 12.75% | 19.10% | 11.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.74% | 6.86% | 25.00% | 10.47% | 8.64% |
| Operating Income | -3.22% | 20.54% | -34.56% | 6.14% | 0.55% |
| Income Before Tax | 13.58% | 31.51% | -66.14% | 21.18% | -25.68% |
| Income Tax Expenses | -22.05% | 35.48% | -181.60% | 353.97% | 20.47% |
| Earnings from Continuing Operations | 30.12% | 30.50% | -42.63% | -7.26% | -36.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -116.67% | 66.67% | 314.29% | -50.00% | -100.00% |
| Net Income | 29.78% | 30.82% | -41.84% | -7.31% | -37.07% |
| EBIT | -3.22% | 20.54% | -34.56% | 6.14% | 0.55% |
| EBITDA | -2.07% | 14.38% | -19.54% | 9.17% | 4.78% |
| EPS Basic | 33.62% | 33.44% | -41.28% | -5.34% | -34.59% |
| Normalized Basic EPS | 0.87% | 25.23% | -36.04% | 1.50% | -3.88% |
| EPS Diluted | 33.77% | 34.07% | -40.77% | -5.69% | -34.75% |
| Normalized Diluted EPS | 0.76% | 25.22% | -36.07% | 1.48% | -3.75% |
| Average Basic Shares Outstanding | -2.88% | -1.96% | -0.95% | -2.08% | -3.79% |
| Average Diluted Shares Outstanding | -2.77% | -1.95% | -0.90% | -2.07% | -3.92% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.25% | -0.25% | 0.70% | 0.04% | 0.53% |